1. Home
  2. Knowledge Base
  3. References
  4. Minocycline in neurodegenerative and psychiatric diseases: An update.

Minocycline in neurodegenerative and psychiatric diseases: An update.

Romero-Miguel D, Lamanna-Rama N, Casquero-Veiga M, Gómez-Rangel V, Desco M, Soto-Montenegro ML (2021) Minocycline in neurodegenerative and psychiatric diseases: An update. Eur J Neurol 28(3):1056-1081. doi: 10.1111/ene.14642

Summary: Review includes the mouse animal model of neurodegenerative disease using mu p75-SAP. Biological Effects: Attenuation of cholinergic neurons loss, glial activation and transcription of pro-inflammatory mediators.

Usage: 45 mg/Kg, i.p.

See: Hunter CL et al. Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning. Eur J Neurosci 19(12):3305-3316, 2004.

Related Products: mu p75-SAP (Cat. #IT-16)